Acquisition Completed
BRUKER acquisition of MIMETAS
Announced Aug 2026 (approx.)
Advisers
MIMETAS
Target
Not disclosed
BRUKER
Acquirer
Not disclosed
Other advisers
- Financial adviser
- Target
- MIMETAS
- Acquirer
- BRUKER
- Target based in
- Netherlands
- Buyer based in
- United States
- Completed
- Aug 2026
- Sector
- Life Sciences
- Tags
- Life Sciences, Biotech
In the league tables
Similar deals
- Oberland Capital Management stake in MeiraGTx Holdings Jul 2026 · Biotech
- Eli Lilly and Company acquisition of Sangamo Therapeutics capsid delivery, zinc finger, modular integrase platforms and prion disease program Jun 2026 · Biotech
- Ligand Pharmaceuticals acquisition of XOMA Royalty Apr 2026 · US$739m · Specialty finance and leasing
- XRA 7 Corp. acquisition of Generation Bio Co. Dec 2025 · Biotech
- Invex Therapeutics acquisition of Rekover Therapeutics Oct 2026 · Healthcare
Sources
- Aug 2026 Raymond James: August 2026 MIMETAS majority stake acquired by BRUKER raymondjames.com
